Cigna Corp (CI)
$191.71
4.24 (2.16%)
18:30 EST
CI Stock Quote Delayed 15 Minutes
Previous Close
$191.71
Market Cap
46.64B
PE Ratio
18.81
EPS
10.19
Volume (Avg. Vol.)
3.34M
Day's Range
189.52 - 195.68
52-Week Range
141.95 - 213.71
Dividend & Yield
0.04 (0.02%)
CI Stock Predictions, Articles, and Cigna Corp News
- From InvestorPlace
- From the Web
7 Sickly Healthcare Stocks to Avoid
The doctor is ordering you to protect your portfolio by avoiding these seven healthcare stocks. There are better investments elsewhere.
Healthcare Stocks: 1 Buy, 1 Sell, 1 Hold
You don't need to avoid healthcare stocks completely. Just be careful where you invest. There's one name Louis Navellier really likes in the space, for example.
10 Healthcare Stocks to Buy Despite the Headlines
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
4 Top Stock Trades for Friday: CGC, MU, BBBY
Cigna, Bed Bath & Beyond, Micron and Canopy Growth were our top stock trades on Thursday as we go into Friday.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Aetna Uncertainty Is Keeping CVS Stock Way Undervalued
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
7 Strong Buy Stocks with More Than Enough Upside
This rally looks like it still has room to run, and top analysts think these 7 "strong buy" stocks can surge higher.
5 Healthcare Stocks to Watch If America Chooses a Single-Payer System
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
4 Sickly Healthcare Stocks to Avoid
These healthcare stocks have each hit a rough road for various reasons. Here's what investors need to know about each.
Cigna Earnings: CI Stock Takes a Hit on Poor Guidance
Cigna earnings for the fourth quarter of the year included poor 2019 guidance, sending CI stock falling on Friday.
7 ‘Strong Buy’ Defensive Stocks For 2019
It’s time to get defensive. Nasdaq has now confirmed's in a bear market. Here are 7 'Strong Buy' defensive stocks to buy now.
3 Healthcare Stocks to Buy Amid the Carnage
Bears have emerged from hibernation. But not all stocks are suffering their wrath. Here are three healthcare stocks to buy.
10 Stocks to Buy As They Soar Higher in Q4 and Beyond
With stocks trading at record levels, it can be difficult to identify the best stocks to buy now. Here are 10 picks that the experts have faith in.
Cigna’s Merger With Express Scripts Is Positive for Cigna Stock
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.
What Cigna Investors Should Expect From Its Latest Victory
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.
Trade of the Day: Express Scripts (ESRX)
Express Scripts (NASDAQ:ESRX), a pharmacy benefit management company operating in the United States and Canada, reported its latest earnings this past Wednesday, Aug. 1, and the stock moved sharply lower when the report crossed the tape.
3 Big Stock Charts for Thursday: Albemarle, Realty Income and CIGNA
The stock charts of CIGNA, Albemarle and Realty Income offer the best reliable technical reads here.
Trade of the Day: Citigroup Flags a Bullish Reversal
Citigroup recently reported earnings and it has since firmly planted a bullish reversal on its charts. This sets up bullish near-term trading opportunities in C stock.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
Sell